• Info
  • Insider Ownership

Insider Trading & Ownership of Atlas Venture Opportunity Fund I, L.P.

Location
Cambridge, MA
Summary
The estimated value of insider holdings of Atlas Venture Opportunity Fund I, L.P. is at least $78,569,200 dollars as of 05 Mar 2024. Atlas Venture Opportunity Fund I, L.P. is the 10%+ Owner of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $69.3M. Atlas Venture Opportunity Fund I, L.P. is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $9.27M.
Signature
Atlas Venture Opportunity Fund I, L.P., By: Atlas Venture Associates Opportunity I, L.P., its general partner, By: Atlas Venture Associates Opportunity I, LLC, its general partner, By: /s/ Ommer Chohan, Chief Financial Officer
All Insider Reports
All Insider Reports

Notify me when Atlas Venture Opportunity Fund I, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Atlas Venture Opportunity Fund I, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. 10%+ Owner $69,297,674 01 Mar 2024
DAWN Day One Biopharmaceuticals, Inc. 10%+ Owner $9,271,526 01 Jul 2022

Insider Transactions Reported by Atlas Venture Opportunity Fund I, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.